facebooktwittertelegramwhatsapp
copy short urlprintemail
+ A
A -
webmaster
Amsterdam The European Medicines Agency (EMA) gave its approval on Thursday for children aged 5 and above to receive the Pfizer/BioNTech vaccine against the coronavirus - making it the first to be green-lighted in the European Union for children under 12.
The move still requires the official approval of the European Commission, but that is considered a formality.
Children aged 5 and above would receive a third of the adult dose of the Pfizer/BioNTech vaccine, followed by a second injection three weeks later.
The EMA stressed that studies showed the vaccine to be safe and effective. No serious side effects had been detected to date, at most mild reactions such as pain at the injection site, tiredness and headaches.
The experts began examining studies conducted by the drug manufacturers in October. (dpa)
copy short url   Copy
26/11/2021
10